The current study demonstrates the added value of a radiomic model to increase the sensitivity and diagnostic performance of determining 1p/19q status in IDH mutant gliomas when compared to the highly specific T2-FLAIR mismatch signature. This evidence concerns the gene IDH1 and glioma.